Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleUrinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification.AuthorsLaroni, A.; Giacomazzi, C.; Grimaldi, L.; Gallo, P.; Sormani, M.; Bertolotto, A.; McDermott, J.; Gandoglia, I.; Martini, I.; Vitello, G.; Rinaldi, F.; Barzon, L.; Militello, V.; Pizzorno, M.; Bandini, F.; Capello, E.; Palù, G.; Uccelli, A.; Mancardi, G.; Varnier, O.PublicationJournal of NeuroImmune Pharmacology, 2012, Vol 7, Issue 3, p665ISSN1557-1890Publication typeArticleDOI10.1007/s11481-012-9366-z